Services

Professional and Cost-Saving Solutions

Computational and Technical Support for High-Throughput Inhibitor Screening

At Creative Enzymes, we recognize that the success of high-throughput screening (HTS) begins long before compounds are tested in the laboratory. Our Computational and Technical Support service provides clients with the essential foundation for efficient, targeted, and scientifically rigorous HTS campaigns. Through a combination of computational modeling, in silico prediction, and expert technical consultation, we optimize the design of inhibitor libraries, streamline assay development, and ensure the efficient allocation of resources. This pre-screening support dramatically enhances hit discovery rates and reduces downstream costs.

Background on Computational and Technical Support for High-Throughput Inhibitor Screening

HTS has become a cornerstone of inhibitor discovery, enabling the rapid evaluation of thousands of compounds across diverse enzyme targets. However, large-scale screening can be resource-intensive, and without proper planning, many campaigns generate low-value hits or inconclusive data. Computational approaches such as molecular docking, virtual screening, pharmacophore modeling, and predictive ADMET analysis provide a powerful first filter to prioritize compounds with higher chances of success.

Computational and technical support for high-throughput inhibitor screening (adapted from Lamba and Pesaresi, 2022)

Equally important, technical consultation helps to define assay conditions, select appropriate controls, and ensure reproducibility in automated workflows. By combining computational and experimental expertise, Creative Enzymes offers an integrated support system that lays the groundwork for robust HTS projects.

Why Computational and Technical Support Matters

Aspect With Computational & Technical Support Without Computational & Technical Support
Compound Selection Prioritized by docking, pharmacophore modeling, and ADMET filtering
→ smaller, higher-value sets
Large, unfocused libraries screened blindly
→ higher cost and time
Hit Rate Enriched libraries increase probability of identifying active inhibitors Lower hit rate due to unfiltered or random compound screening
Assay Development Tailored guidance on substrates, controls, and conditions ensures robust, reproducible assays Trial-and-error assay setup
→ higher variability and inconsistent results
Resource Efficiency Streamlined experiments reduce costs, reagent consumption, and automation time Wasted resources on screening low-probability candidates
Timeline Faster progression from library selection to validated hits Extended project duration due to redundant testing and re-optimization
Integration with HTS Workflow Smooth transition from in silico predictions to automated HTS No link between computational predictions and experimental testing

Our Solid Support Services

Our Computational and Technical Support services focus on three main pillars:

Computational Modeling & Prediction

  • Virtual screening of large libraries to rank compounds by predicted binding affinity.
  • Molecular docking to model inhibitor–enzyme interactions and identify key binding residues.
  • Pharmacophore modeling to highlight structural motifs critical for inhibition.
  • In silico ADMET evaluation to predict solubility, stability, and potential toxicity.

Technical Consultation

  • Guidance on experimental design, including enzyme selection, substrate optimization, and assay format.
  • Advice on automation compatibility for high-throughput workflows.
  • Recommendations for positive/negative controls and reference inhibitors.
  • Risk assessment to identify potential challenges in assay reproducibility

Integration with HTS Workflow

  • Seamless connection between computational predictions and wet-lab experiments.
  • Prioritization of compound subsets for efficient screening.
  • Continuous support during the assay development phase.

Contact Our Team

Looking Ahead: The Complete Workflow for High-Throughput Screening of Inhibitors

Beyond computational and technical support, Creative Enzymes provides a comprehensive, end-to-end high-throughput screening (HTS) process for enzyme inhibitors. Our services are organized into dedicated modules, allowing clients to select the support they need or follow the full workflow seamlessly:

Comprehensive workflow for high-throughput screening of enzyme inhibitors

Construction of Inhibitor Libraries for High-Throughput Screening

Design or access tailored compound libraries for your target enzymes.

Inquiry

High-Throughput Inhibitor Assays and Screening

Perform automated, scalable assays to rapidly evaluate thousands of candidates.

Inquiry

Determination and Measurement of Inhibitor Activity

Precisely quantify potency, specificity, and kinetic parameters of identified hits.

Inquiry

Why Choose Creative Enzymes

Integrated Computational–Experimental Approach

Ensures smooth transition from in silico predictions to experimental assays.

Broad Enzyme Coverage

Modeling and consultation available for diverse enzyme classes, from kinases to glycosidases.

Tailored Recommendations

Customized guidance based on the client's specific research objectives.

Efficiency and Cost Reduction

Prioritization of compound subsets reduces unnecessary screening costs.

Cutting-edge Computational Tools

Access to molecular docking, pharmacophore modeling, and predictive ADMET platforms.

Expert Consultation

Our enzymology experts provide practical, hands-on advice for assay development and workflow optimization.

Case Studies and Success Stories

Case 1: Pre-Screening for Deacetylase Inhibitors

Client Need:

A pharmaceutical company aimed to discover novel deacetylase inhibitors but faced challenges in managing the costs and time associated with screening a very large compound library.

Our Approach:

We applied molecular docking, virtual screening, and pharmacophore modeling to pre-screen 5,000 candidate compounds. Using computational ranking, we identified the 500 most promising candidates predicted to interact strongly with the deacetylase active site. These prioritized compounds were advanced to HTS, significantly reducing unnecessary experimental workload.

Outcome:

HTS revealed a notably higher hit rate among the computationally enriched set compared with random screening. The client successfully advanced multiple lead candidates into SAR optimization, saving both time and resources.

Case 2: Optimizing Lipase Assays for High-Throughput Screening

Client Need:

A food biotechnology company needed reliable HTS-compatible lipase inhibition assays to support large-scale screening. Their primary concern was reproducibility across thousands of wells under automated conditions.

Our Approach:

Our technical team optimized assay conditions, carefully selecting substrates, buffer systems, and reference controls to ensure robustness. We also provided recommendations for automation integration, ensuring that the assay remained consistent under high-throughput robotic workflows.

Outcome:

The optimized assay produced reproducible results across large compound sets, enabling the client to carry out screening at scale with confidence. This reliability reduced false positives and ensured smoother downstream hit validation.

FAQs About Computational and Technical Support for Inhibitor HTS

  • Q: What computational tools do you use for pre-screening?

    A: We employ a combination of molecular docking, virtual screening, pharmacophore modeling, and in silico ADMET analysis. These methods allow us to rank compounds based on predicted binding affinity and assess their drug-like properties.
  • Q: Can you integrate client-provided compound libraries into the computational workflow?

    A: Absolutely. We can work with client-supplied libraries, pre-built libraries from our platform, or construct hybrid libraries for specific targets.
  • Q: How does technical consultation improve HTS outcomes?

    A: Our consultation ensures that assay design, substrate selection, and automation workflows are optimized. This reduces experimental variability and increases hit identification efficiency.
  • Q: How do you ensure computational predictions align with experimental results?

    A: We integrate computational data with experimental validation. By prioritizing compounds and designing assays based on predicted binding modes, we create a synergistic workflow that bridges in silico and wet-lab results.
  • Q: What types of enzyme targets are best suited for computational pre-screening?

    A: Most enzyme families—including kinases, proteases, lipases, esterases, glycosidases, and novel targets—are suitable. For emerging enzymes, we can build structural models based on homology.

Reference:

  1. Lamba D, Pesaresi A. Kinetic modeling of time-dependent enzyme inhibition by pre-steady-state analysis of progress curves: the case study of the anti-Alzheimer's drug galantamine. IJMS. 2022;23(9):5072. doi:10.3390/ijms23095072

For research and industrial use only, not for personal medicinal use.

Services
Online Inquiry

For research and industrial use only, not for personal medicinal use.